With the emergence of contract research organizations, the pharmaceutical industry is receiving much needed support for functions including medical research, drug development, and drug marketing in one package. The appearance of contract research organizations, or CRO, in Japan provides this technology-leading country with a more integrated approach to pharmaceutical R&D. Below is an analysis of the benefits of drug manufacturing with Japanese CROs.
1. Reduced time to market – the comprehensive nature of CRO services provide for faster time to market from research to development to market to sales
2. Leading pharmaceutical companies in Japan – Japan is the second largest pharmaceutical industry in the world and holds a competitive advantage in new drug development
3. Reduce costs – Drugs enter the market at a faster pace, without compromising quality, yields less costs and quicker profit build up
4. Greater flexibility – CROs allow for maximizing expertise while minimizing internal resources
The benefits of drug manufacturing with Japanese CROs are endless. They are taking a more robust role in drug development among other services, thus offer attractive one-stop shop models for clients. They are just as able to provide regulatory support, clinical development support, and execution support.
Sources: http://www.aboutanimaltesting.co.uk/contract-research-organisations.html
http://www.genengnews.com/gen-articles/cro-relationships-get-more-serious/3346/
http://pharmalicensing.com/public/articles/view/1194605405_47343b5d9ec4b